Case Challenge

Management of Initial HBV Therapy for an HBeAg-Negative Patient

Source: HBV Treatment: What to Start?

Management of Initial HBV Therapy for an HBeAg-Negative Patient

Faculty:

Calvin Q. Pan, MD, FACP, FACG

CREDIT INFORMATION

Release Date: 06/09/09

Expiration Date: 06/08/10

Physicians: maximum of 0.75 AMA PRA Category 1 Credits™

Registered Nurses: 0.8 Nursing contact hours

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

Describe clinical considerations relevant to the choice of an optimal initial HBV treatment strategy for HBeAg-negative patients
Compare and contrast the latest clinical data and best practices regarding treatment strategies for treatment-naive patients with HBeAg-negative chronic HBV infection
Synthesize and apply differences in initial management strategies for patients with HBeAg-negative chronic HBV infection

Test your ability to make optimal treatment decisions using patient histories and diagnostic information and see the case unfold according to your choices. Compare your answers with your peers and our expert faculty’s recommendations, and then review the supporting data.

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.